Tarsus Pharmaceuticals (TARS) announced the commencement of an underwritten public offering of $100M of shares of its common stock. All shares in the proposed offering are to be sold by Tarsus.

These ratings convey expectations for the relative performance of Ionis Pharmaceuticals compared to the broader market. Price Targets: Analysts set price targets as an estimate of a stock's future ...

Ionis Pharmaceuticals IONS underwent analysis ... banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial ...

but all three stocks have declined at least 25% from their highs. Pharmaceutical stock Gilead Sciences is the best performing member of the Nasdaq-100 in 2025, and the company has several ...

However, the stock was also likely negatively impacted by CNBC Mad Money host Jim Cramer's comments on Friday. He expressed reservations about buying shares of Recursion Pharmaceuticals in light ...

Lexicon Pharmaceuticals LXRX has been analyzed by ... analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference ...

Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Here are four things you should know if you're thinking of buying Recursion Pharmaceuticals ...

Shares of NYSE LLY traded up $10.29 on Wednesday, reaching $921.35. 1,329,631 shares of the company’s stock traded hands, compared to its average volume of 3,108,473. The company has a market ...

Following the earnings announcement, Xeris Pharmaceuticals’ stock rose 8.49% in premarket trading, reaching $4.09. According to InvestingPro data, analysts maintain a strong buy consensus on the ...

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Vertex Pharmaceuticals fits this criterion perfectly. VRTX has a robust clinical pipeline of ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers. The generic pharmaceutical industry operates ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers. The generic pharmaceutical industry operates on ...